Intuitive Surgical, Inc. (ISRG) is poised to unveil its first-quarter financial results, with Wall Street expectations pointing towards significant growth. Analysts predict the company will report earnings of $1.40 per share, marking a 13.8% increase from the previous year, alongside projected revenues of $1.86 billion, up by 9.9%.
The consensus on earnings per share (EPS) for Intuitive Surgical has remained stable over the past month, indicating a solid agreement among analysts on the anticipated results. Such stability in earnings estimates is crucial as it often influences investor sentiment and stock performance in the run-up to the earnings announcement.
Earnings revisions are a key indicator to consider ahead of the company’s earnings release, as they can significantly impact how the market reacts to the actual results. Historical data underscores a robust link between the direction of earnings estimate revisions and subsequent stock price movements.
Investors typically focus on consensus earnings and revenue forecasts to gauge a company’s performance for the quarter. However, a deeper analysis into specific financial metrics provided by analysts can offer a more nuanced view of the company’s health.
For this quarter, projections for Intuitive Surgical’s ‘Revenue-Products (Instruments and Systems)’ are set at $1.54 billion, an 8.8% increase from the previous year. Service revenues are also expected to rise, with forecasts at $318.93 million, up 12.6%.
Conversely, ‘Revenue-Systems’ is anticipated to decline by 8.8%, totaling $389.71 million. In contrast, ‘Revenue- Instruments and accessories’ are predicted to grow significantly, reaching $1.15 billion, a 16.5% increase from last year.
In terms of operational metrics, the ‘Total System Units Placed – Total Company’ is estimated at 283 units, down from 312 units a year earlier. The ‘Da Vinci Surgical System Installed Base’ is expected to grow, with a projected count of 8,775 units compared to last year’s 7,779.
Domestically, ‘Total System Units Placed – United States’ is anticipated to be 110, showing a decrease from 141 units placed during the same quarter last year.
Financially, the ‘Gross profit- Service’ is projected at $216.78 million, up from $193 million previously, while ‘Gross profit- Product’ is expected to hit $1.03 billion, up from $920 million. Additionally, the ‘Cost of sales- Services’ and ‘Cost of sales- Products’ are forecasted at $95.69 million and $533.88 million, respectively, reflecting changes from the prior year.
As Intuitive Surgical gears up to report its first-quarter earnings, investors and stakeholders are keenly watching these projections. With an overall stable outlook and expected growth in key areas, ISRG is looking to maintain its trajectory in the competitive medical devices market. Despite a slight downturn in its stock performance relative to the broader market, the company holds a Zacks Rank #3 (Hold), indicating potential alignment with market trends in the near term. For more detailed insights and up-to-date stock rankings, interested parties can visit Zacks’ investment research platform.